Contact
Please use this form to send email to PR contact of this press release:
Cantabio Pharmaceuticals to Present Results from its DJ-1 Protein Targeting Therapeutic Programs at the 4th World Parkinson’s Congress and 3rd International Parkinson’s Disease Symposium
TO: